Detection of clonality with κ and λ immunohistochemical analysis in cutaneous plasmacytomas

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 6, 2004, Pages 645-648

  Bayer Garner, Ilene B ^a   Prieto, Victor G ^b   Smoller, Bruce R ^c  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

CLONAL VARIATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIGHT CHAIN; MULTIPLE MYELOMA; PLASMA CELL; PLASMACYTOMA; REVIEW; TISSUE SECTION; ARTICLE; CELL CLONE; PATHOLOGY; SKIN TUMOR;

CLONE CELLS; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOHISTOCHEMISTRY; MULTIPLE MYELOMA; PLASMACYTOMA; SKIN NEOPLASMS;

EID: 4844219648     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Bayer-Garner IB, Smoller BR. The spectrum of cutaneous disease in multiple myeloma. J Am Acad Dermatol. 2003;48:497-507.
2. Sirot G. Cutaneous manifestations of multiple myeloma. Cutis. 1979;23:174-177.
3. Bluefarb SM. Cutaneous manifestations of multiple myeloma. Arch Dermatol. 1955;72:506-522.
4. Wuepper KD, MacKenzie MR. Cutaneous extramedullary plasmacytomas. Arch Dermatol. 1969;100:155-164.
5. Patterson JW, Parsons JM, White RM, Fitzpatrick JE, Kohout-Dutz E. Cutaneous involvement of multiple myeloma and extramedullary plasmacytoma. J Am Acad Dermatol. 1988;19:879-890.
6. Jorizzo JL, Gammon WR, Briggaman RA. Cutaneous plasmacytomas: a review and presentation of an unusual case. J Am Acad Dermatol. 1979;1:59-66.
7. Mukunyadzi P, Bardales RH, Wilson CS, Sawyer JR, Stanley MW. Soft tissue masses in patients with multiple myeloma, a fine-needle aspiration study of 30 cases with flow cytometry and clinical correlation. Cancer. 2001;93:257-262.
8. Boo K, Cheng S. A morphological and immunohistochemical study of plasma cell proliferative lesions. Malays J Pathol. 1992;14:45-48.
9. Bayer-Garner IB, Lin P, Smoller BR. CD117, but not lysozyme, is positive in cutaneous plasmacytoma. Arch Pathol Lab Med 2003;127:1596-1598.
10. Bayer-Garner IB, Joseph L, Sanderson RD, Smoller BR. Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma. J Cutan Pathol. 2003;30:18-22.
11. Ocqueteau M, Orfao A, Garcia-Sanz R, Almeida J, Gonzalez M, San Miguel JF. Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells. Br Haematol. 1996;95:489-493.
12. Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characteristics of plasma cells from monoclonal gammopathy of undetermined significance patients: implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol. 1998;152:1655-1665.
13. Aguilera NS, Kapadia SB, Nalesnik MA, Swerdlow SH. Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol. 1995;8:503-508.
14. Burg G, Kerl H, Kaudewitz P, Braun-Falco O, Mason DY. Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. J Dermatol Surg Oncol. 1984;10:284-290.
15. Bartl R, Frisch B, Burkhardt R, et al. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging. Br J Haematol. 1982;51:361-375.
16. Requena L, Kutzner H, Palmedo G, et al. Cutaneous involvement in multiple myeloma. Arch Dermatol. 2003;139:475-486.
17. Kois JM, Lookingbill DP. Cutaneous manifestations of multiple myeloma. Arch Dermatol. 1991;127:69-74.
18. Alberts DS, Lynch P. Cutaneous plasmacytomas in myeloma. Arch Dermatol. 1978;114:1784-1787.
19. Hobbs JR, Corbett AA. Younger age of presentation and extraosseous tumor in IgD myelomatosis. Br J Med. 1969;1:412-414.
20. Holland J, Trenkner D, Asserman TW, Fineberg B. Plasmacytoma:treatment results and conversion to myeloma. Cancer. 1992;69:1513-1517.